Last reviewed · How we verify
Withdrawal of Spironolactone — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Withdrawal of Spironolactone (Withdrawal of Spironolactone) — Asan Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Withdrawal of Spironolactone TARGET | Withdrawal of Spironolactone | Asan Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Withdrawal of Spironolactone CI watch — RSS
- Withdrawal of Spironolactone CI watch — Atom
- Withdrawal of Spironolactone CI watch — JSON
- Withdrawal of Spironolactone alone — RSS
Cite this brief
Drug Landscape (2026). Withdrawal of Spironolactone — Competitive Intelligence Brief. https://druglandscape.com/ci/withdrawal-of-spironolactone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab